Psychogenics, Inc.

Tarrytown, NY 10591

SBIR Award Summary

Total Number of Awards 47
Total Value of Awards $13.8MM
First Award Date 08/12/02
Most Recent Award Date 08/01/15

Key Personnel

Last Name Name Awards Contact
Toretsky Jeffrey A Toretsky 1
Johnson Kenneth M Johnson 2
Yakovlev Alexander G Yakovlev 2
Kottmann Andreas H Kottmann 1
Brunner Daniela Brunner 12
Leahy Emer Leahy 6
Brownell Anna-Liisa Brownell 3
Tueckmantel Werner Tueckmantel 6
Zhou Jia Zhou 6
Caldarone Barbara J Caldarone 2
Mcgonigle Paul Mcgonigle 3
Lowe David Anthony Lowe 2
HANANIA TALEEN G HANANIA 1

47 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-12-088
Budget: 08/01/15 - 07/31/16

DESCRIPTION (provided by applicant): Despite great advances in both the understanding of the neurobiology of addiction and the development and approval of smoking cessation therapies, a significant need remains for better smoking cessation aids. Our goal is aligned with NIDA's intent to bring the power of science to bear on drug abuse and addict...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-12-088
Budget: 09/30/14 - 07/31/15

DESCRIPTION (provided by applicant): Despite great advances in both the understanding of the neurobiology of addiction and the development and approval of smoking cessation therapies, a significant need remains for better smoking cessation aids. Our goal is aligned with NIDA's intent to bring the power of science to bear on drug abuse and addict...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-12-088
Budget: 09/15/12 - 08/31/13

DESCRIPTION (provided by applicant): Despite great advances in both the understanding of the neurobiology of addiction and the development and approval of smoking cessation therapies, a significant need remains for better smoking cessation aids. Our goal is aligned with NIDA's intent to bring the power of science to bear on drug abuse and addict...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-142
Budget: 07/01/12 - 06/30/13

DESCRIPTION (provided by applicant): Schizophrenia is a common and highly disabling psychiatric disorder with a population prevalence around 1%. The manifestations of schizophrenia fall into three major domains: 1) "positive" symptoms;2) "negative" symptoms: and 3) cognitive dysfunction. All marketed therapies for the treatment of Schizophrenia ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-142
Budget: 07/18/11 - 06/30/12

DESCRIPTION (provided by applicant): Schizophrenia is a common and highly disabling psychiatric disorder with a population prevalence around 1%. The manifestations of schizophrenia fall into three major domains: 1) "positive" symptoms;2) "negative" symptoms: and 3) cognitive dysfunction. All marketed therapies for the treatment of Schizophrenia ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-07-280
Budget: 03/01/10 - 08/31/10

DESCRIPTION (provided by applicant): Pancreatic cancer is the fifth leading cause of cancer death in the US. Despite tremendous efforts aimed at understanding its molecular biology, conventional treatment has had little impact. Due to the highly metastatic nature of the disease, surgery is available to only 15- 20% of patients. Thus, the develop...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-027
Budget: 11/01/09 - 10/31/10

DESCRIPTION (provided by applicant): This Phase II application is being submitted in response to a continuing NIMH program announcement for Pharmacological Agents and Drugs for Mental Disorders. The goal of the proposal is to use an innovative behavior-driven approach to psychiatric drug discovery to overcome the major limitations associated wit...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-07-280
Budget: 09/01/09 - 02/28/10

DESCRIPTION (provided by applicant): Pancreatic cancer is the fifth leading cause of cancer death in the US. Despite tremendous efforts aimed at understanding its molecular biology, conventional treatment has had little impact. Due to the highly metastatic nature of the disease, surgery is available to only 15- 20% of patients. Thus, the develop...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-027
Budget: 06/01/09 - 05/31/11

DESCRIPTION (provided by applicant): Schizophrenia is a chronic, severe, and disabling brain disease. Nearly 1 percent of the population develops schizophrenia during their lifetime - more than 2 million Americans suffer from this disease in a given year. The schizophrenia world market generated total revenues of nearly $12 billion in 2004 and i...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-07-280
Budget: 03/01/09 - 02/28/11

DESCRIPTION (provided by applicant): Traumatic brain injury (TBI) is a serious public health concern. It is estimated that severe TBI will become the third most common cause of death and disability globally by the year 2020. An estimated 1.5 million persons sustain a TBI in the United States annually resulting in more than 230,000 hospitalizatio...

Load More